CURE4h
Evolving Treatments and Advances in HER2-Positive Breast Cancer
Dr. Sara M. Tolaney discussed HER2-positive breast cancer, highlighting key trials, evolving treatment strategies, and the ...
CURE6h
What Patients With Breast Cancer Need to Know About Itovebi
Itovebi, approved for some patients with breast cancer, is the first PI3K inhibitor to display a survival benefit, according ...
Public Broadcasting Service (PBS)7h
Ovarian cancer blood test misses some Black and Native American patients, study finds
A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...
American Cancer Society9h
Personal Loss Drives Cancer Researcher Toward CAR T-Cell Research Breakthroughs
Now, as a scientist at the University of Pennsylvania, Charly is working to rewrite the future of cancer treatment.
The American Journal of Managed Care12h
Dr Toon Van Gorp: Mirvetuximab Soravtansine Should Be Global Standard for FRα+ Ovarian Cancer
Toon Van Gorp, MD, PhD, a MIRASOL trial investigator, emphasizes that the final analysis reinforces the efficacy of mirvetuximab soravtansine-gynx (Elahere; AbbVie) in patients with folate receptor ...
News-Medical.Net13h
Breast cancer survivors face accelerated aging tied to tumors and treatment
Accelerated aging in breast cancer survivors is linked to treatments and tumor characteristics, with implications for ...